Johnson & Johnson - 63 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1962 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of April 15, 2025 is 153.62.
  • The all-time high Johnson & Johnson stock closing price was 170.24 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 169.99, which is 10.7% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 140.68, which is 8.4% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 154.99.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 155.4086 142.8760 167.7000 140.9320 153.6200 7.07%
2024 151.8204 153.8300 164.7290 139.9600 143.4720 -4.81%
2023 151.7393 166.3040 168.2260 138.8990 150.7240 -8.58%
2022 158.8975 155.9990 170.2430 144.7360 164.8660 5.97%
2021 148.5729 138.8230 161.1900 136.6270 155.5710 11.44%
2020 127.5635 126.0550 139.6030 96.5891 139.6030 10.82%
2019 114.8358 107.2960 126.4610 105.5910 125.9690 16.22%
2018 110.1942 113.8500 124.1700 98.9890 108.3880 -5.13%
2017 104.7669 92.3251 116.8430 89.0733 114.2510 24.43%
2016 89.3277 77.8819 98.6008 74.2157 91.8230 15.33%
2015 76.1654 78.6814 81.5792 69.8101 79.6182 1.14%
2014 74.8876 66.6776 81.6926 63.4474 78.7191 17.34%
2013 61.9165 50.3594 70.0470 50.2883 67.0878 34.62%
2012 46.7193 45.1624 51.1018 43.1417 49.8333 10.85%
2011 42.7649 41.5525 45.7253 38.4843 44.9567 9.89%
2010 40.3628 41.3249 42.5102 37.0449 40.9108 -0.59%
2009 36.3363 37.4915 41.5038 29.0452 41.1524 11.27%
2008 39.5182 39.6028 44.2756 34.2029 36.9846 -7.72%
2007 37.9398 38.9030 41.0989 35.3580 40.0774 3.61%
2006 36.0237 35.2783 40.2575 32.5135 38.6803 12.43%
2005 36.6540 35.3071 39.1243 34.3682 34.4025 -3.36%
2004 31.0816 28.4399 35.7898 27.3709 35.5990 25.17%
2003 28.6875 29.9186 31.8552 26.6989 28.4399 -2.08%
2002 30.9476 31.3133 35.0440 22.4702 29.0426 -7.88%
2001 27.5767 27.0352 32.5243 22.0655 31.5267 13.21%
2000 23.6606 24.4344 27.8470 18.1560 27.8470 12.67%
1999 24.9230 21.9164 28.1285 20.4089 24.7160 11.18%
1998 19.8845 17.2449 23.5895 16.9632 22.2311 27.32%
1997 15.8095 13.1862 17.7418 13.1862 17.4602 32.41%
1996 12.8724 11.1652 14.2464 11.0990 13.1862 16.37%
1995 9.1205 7.2226 12.1260 7.1232 11.3309 56.17%
1994 6.1221 5.9968 7.3883 4.8703 7.2557 22.00%
1993 5.5653 6.5600 6.5600 4.7212 5.9471 -11.14%
1992 6.5411 7.4379 7.7112 5.7152 6.6925 -11.79%
1991 5.9402 4.6381 7.6532 4.3482 7.5869 59.59%
1990 4.1640 3.9671 4.8617 3.4453 4.7541 20.85%
1989 3.3163 2.7703 3.9340 2.7703 3.9340 39.50%
1988 2.6823 2.5881 2.9194 2.3024 2.8200 13.69%
1987 2.8552 2.2319 3.4660 2.1368 2.4804 14.09%
1986 2.1106 1.7185 2.4473 1.5819 2.1740 24.70%
1985 1.4755 1.1802 1.8137 1.1636 1.7434 45.68%
1984 1.1359 1.3541 1.4038 0.9358 1.1967 -11.62%
1983 1.5128 1.6398 1.6936 1.3002 1.3541 -17.63%
1982 1.3531 1.2133 1.6895 1.0767 1.6440 33.67%
1981 1.1316 1.1029 1.2754 0.9442 1.2299 11.66%
1980 0.8763 0.8475 1.1042 0.7343 1.1015 25.87%
1979 0.7962 0.8199 0.8834 0.7150 0.8751 7.45%
1978 0.8475 0.8282 0.9800 0.7274 0.8144 -3.91%
1977 0.7769 0.8627 0.8627 0.6915 0.8475 -1.60%
1976 0.9534 0.9952 1.0615 0.7951 0.8613 -13.10%
1975 0.9824 0.9165 1.0932 0.8144 0.9911 10.97%
1974 1.0885 1.2340 1.3127 0.8296 0.8931 -28.27%
1973 1.3127 1.4190 1.4411 1.1540 1.2451 -13.60%
1972 1.3022 1.0794 1.4590 1.0477 1.4411 32.49%
1971 0.9399 0.6322 1.0918 0.6322 1.0877 72.82%
1970 0.5681 0.6460 0.6543 0.4127 0.6294 -5.01%
1969 0.4705 0.3893 0.6626 0.3727 0.6626 69.03%
1968 0.3256 0.3313 0.3920 0.2751 0.3920 16.08%
1967 0.2819 0.2074 0.3524 0.2037 0.3377 60.96%
1966 0.2131 0.2147 0.2454 0.1716 0.2098 -0.71%
1965 0.1703 0.1365 0.2141 0.1365 0.2113 54.12%
1964 0.1289 0.1281 0.1460 0.1178 0.1371 9.59%
1963 0.1102 0.0917 0.1455 0.0911 0.1251 39.15%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $394.223B $88.821B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $835.717B 67.80
Novo Nordisk (NVO) Denmark $406.526B 27.53
AbbVie (ABBV) United States $360.274B 20.17
Roche Holding AG (RHHBY) Switzerland $264.748B 0.00
Merck (MRK) United States $230.880B 11.95
Novartis AG (NVS) Switzerland $223.246B 13.98
Pfizer (PFE) United States $151.025B 8.57
Sanofi (SNY) $136.409B 12.92
Bayer (BAYRY) Germany $23.028B 3.69
Innoviva (INVA) United States $1.132B 9.42